Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 24 | 2025 | 309 | 5.010 |
Why?
|
| Trypanosoma cruzi | 22 | 2025 | 251 | 4.170 |
Why?
|
| Microbiota | 4 | 2024 | 443 | 1.270 |
Why?
|
| Host-Parasite Interactions | 3 | 2025 | 80 | 1.080 |
Why?
|
| Protozoan Vaccines | 3 | 2024 | 96 | 1.070 |
Why?
|
| Ascariasis | 2 | 2024 | 73 | 1.070 |
Why?
|
| Vaccines | 4 | 2024 | 380 | 1.010 |
Why?
|
| RNA, Messenger | 5 | 2025 | 2877 | 0.960 |
Why?
|
| Leishmaniasis | 1 | 2024 | 40 | 0.880 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family Member 1 | 1 | 2020 | 6 | 0.690 |
Why?
|
| Macrophages | 2 | 2025 | 697 | 0.660 |
Why?
|
| Parasites | 1 | 2020 | 37 | 0.660 |
Why?
|
| Immunity, Innate | 2 | 2024 | 415 | 0.660 |
Why?
|
| Rhodnius | 2 | 2017 | 2 | 0.660 |
Why?
|
| Transcription, Genetic | 2 | 2024 | 1757 | 0.600 |
Why?
|
| Virulence Factors | 2 | 2023 | 187 | 0.570 |
Why?
|
| DNA, Protozoan | 2 | 2018 | 32 | 0.570 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 142 | 0.560 |
Why?
|
| Spike Glycoprotein, Coronavirus | 5 | 2023 | 204 | 0.550 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 527 | 0.540 |
Why?
|
| Plant Leaves | 1 | 2017 | 54 | 0.520 |
Why?
|
| Insect Vectors | 1 | 2017 | 114 | 0.500 |
Why?
|
| Cytokines | 3 | 2018 | 1378 | 0.470 |
Why?
|
| Animals | 27 | 2025 | 36217 | 0.460 |
Why?
|
| Rhodococcus equi | 2 | 2025 | 7 | 0.450 |
Why?
|
| Actinomycetales Infections | 2 | 2025 | 15 | 0.450 |
Why?
|
| Horse Diseases | 2 | 2025 | 37 | 0.450 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 510 | 0.420 |
Why?
|
| Chagas Cardiomyopathy | 3 | 2021 | 52 | 0.370 |
Why?
|
| Mice, Inbred BALB C | 8 | 2025 | 1083 | 0.370 |
Why?
|
| Adjuvants, Immunologic | 2 | 2024 | 391 | 0.370 |
Why?
|
| Mice | 16 | 2025 | 18936 | 0.310 |
Why?
|
| Horses | 3 | 2025 | 102 | 0.280 |
Why?
|
| Immunization, Passive | 2 | 2025 | 129 | 0.270 |
Why?
|
| Antibodies, Protozoan | 2 | 2025 | 95 | 0.270 |
Why?
|
| Antigens, Protozoan | 2 | 2024 | 80 | 0.270 |
Why?
|
| Technology | 2 | 2024 | 70 | 0.260 |
Why?
|
| Arecaceae | 2 | 2017 | 2 | 0.250 |
Why?
|
| Recombinant Proteins | 4 | 2023 | 1433 | 0.250 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2025 | 10 | 0.240 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2023 | 440 | 0.230 |
Why?
|
| Metabolome | 2 | 2020 | 322 | 0.230 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2025 | 59 | 0.230 |
Why?
|
| Prebiotics | 1 | 2024 | 29 | 0.220 |
Why?
|
| Ascaris suum | 1 | 2024 | 32 | 0.220 |
Why?
|
| Transfection | 2 | 2024 | 1095 | 0.220 |
Why?
|
| Antibody Formation | 1 | 2025 | 273 | 0.220 |
Why?
|
| Saccharomycetales | 2 | 2021 | 38 | 0.220 |
Why?
|
| Extracellular Matrix | 1 | 2025 | 242 | 0.220 |
Why?
|
| Larva | 1 | 2024 | 254 | 0.210 |
Why?
|
| RNA Caps | 1 | 2024 | 32 | 0.210 |
Why?
|
| Myocarditis | 2 | 2015 | 133 | 0.210 |
Why?
|
| Trypanocidal Agents | 1 | 2023 | 31 | 0.210 |
Why?
|
| Nitroimidazoles | 1 | 2023 | 44 | 0.210 |
Why?
|
| Protozoan Proteins | 1 | 2024 | 135 | 0.210 |
Why?
|
| Parasite Load | 2 | 2020 | 31 | 0.210 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 96 | 0.210 |
Why?
|
| Tissue Distribution | 1 | 2024 | 400 | 0.210 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2024 | 404 | 0.200 |
Why?
|
| Immune System | 1 | 2023 | 98 | 0.190 |
Why?
|
| Iron | 1 | 2025 | 304 | 0.190 |
Why?
|
| Molecular Typing | 3 | 2017 | 34 | 0.190 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 294 | 0.190 |
Why?
|
| Models, Animal | 1 | 2024 | 483 | 0.190 |
Why?
|
| Colombia | 3 | 2017 | 48 | 0.190 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 4760 | 0.190 |
Why?
|
| Probiotics | 1 | 2024 | 229 | 0.180 |
Why?
|
| RNA, Protozoan | 1 | 2021 | 10 | 0.180 |
Why?
|
| Antibodies, Monoclonal | 2 | 2025 | 1049 | 0.180 |
Why?
|
| Zebrafish | 1 | 2024 | 422 | 0.180 |
Why?
|
| Humans | 20 | 2024 | 133331 | 0.180 |
Why?
|
| Nasal Sprays | 1 | 2021 | 8 | 0.180 |
Why?
|
| Tropism | 1 | 2020 | 11 | 0.170 |
Why?
|
| Immunodominant Epitopes | 1 | 2021 | 52 | 0.170 |
Why?
|
| Death, Sudden | 1 | 2021 | 48 | 0.170 |
Why?
|
| NADPH Oxidase 2 | 1 | 2020 | 41 | 0.170 |
Why?
|
| Vero Cells | 1 | 2020 | 113 | 0.170 |
Why?
|
| RNA | 1 | 2024 | 606 | 0.170 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 98 | 0.170 |
Why?
|
| Myocardium | 3 | 2020 | 924 | 0.160 |
Why?
|
| Gene Expression | 2 | 2021 | 1608 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 822 | 0.160 |
Why?
|
| Phylogeny | 3 | 2018 | 781 | 0.160 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 230 | 0.160 |
Why?
|
| Heart | 2 | 2021 | 712 | 0.150 |
Why?
|
| Transients and Migrants | 2 | 2016 | 22 | 0.150 |
Why?
|
| Genome, Protozoan | 1 | 2018 | 26 | 0.150 |
Why?
|
| DNA | 1 | 2024 | 1676 | 0.140 |
Why?
|
| Autoantibodies | 1 | 2021 | 464 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2020 | 824 | 0.140 |
Why?
|
| Multigene Family | 1 | 2018 | 321 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 453 | 0.140 |
Why?
|
| Dendritic Cells | 1 | 2020 | 449 | 0.140 |
Why?
|
| Thymocytes | 1 | 2017 | 9 | 0.140 |
Why?
|
| Lymphopoiesis | 1 | 2017 | 10 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 509 | 0.140 |
Why?
|
| Insect Control | 1 | 2017 | 13 | 0.130 |
Why?
|
| Thymus Gland | 1 | 2017 | 106 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2020 | 3979 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1051 | 0.130 |
Why?
|
| Ecosystem | 1 | 2017 | 110 | 0.120 |
Why?
|
| Protein Domains | 3 | 2021 | 260 | 0.120 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 1 | 2015 | 8 | 0.120 |
Why?
|
| Arginine | 1 | 2018 | 350 | 0.120 |
Why?
|
| Cell Line | 1 | 2020 | 2853 | 0.120 |
Why?
|
| Dinoprostone | 1 | 2015 | 82 | 0.120 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 140 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2017 | 439 | 0.110 |
Why?
|
| Base Sequence | 1 | 2018 | 3153 | 0.110 |
Why?
|
| Antibodies, Neutralizing | 3 | 2023 | 498 | 0.110 |
Why?
|
| Trypanosomiasis | 1 | 2013 | 2 | 0.110 |
Why?
|
| Genotype | 2 | 2017 | 2720 | 0.100 |
Why?
|
| Chiroptera | 1 | 2013 | 17 | 0.100 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2025 | 59 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2025 | 4823 | 0.100 |
Why?
|
| HIV Infections | 1 | 2024 | 2075 | 0.090 |
Why?
|
| Antibodies, Viral | 3 | 2023 | 1205 | 0.090 |
Why?
|
| B-Lymphocytes | 2 | 2025 | 542 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2017 | 2026 | 0.080 |
Why?
|
| Bacterial Proteins | 2 | 2025 | 924 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2023 | 1041 | 0.070 |
Why?
|
| Female | 10 | 2025 | 71482 | 0.070 |
Why?
|
| Bolivia | 2 | 2016 | 15 | 0.060 |
Why?
|
| Spain | 2 | 2016 | 65 | 0.060 |
Why?
|
| Lung | 2 | 2024 | 1571 | 0.060 |
Why?
|
| Endemic Diseases | 2 | 2016 | 59 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2024 | 107 | 0.050 |
Why?
|
| Hepatomegaly | 1 | 2023 | 22 | 0.050 |
Why?
|
| PPAR alpha | 1 | 2023 | 54 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2021 | 1235 | 0.050 |
Why?
|
| Immunity, Humoral | 1 | 2023 | 75 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2025 | 431 | 0.050 |
Why?
|
| HIV | 1 | 2024 | 193 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2025 | 424 | 0.050 |
Why?
|
| Alum Compounds | 1 | 2022 | 42 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 356 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 520 | 0.050 |
Why?
|
| Hybridomas | 1 | 2021 | 41 | 0.050 |
Why?
|
| Polyethyleneimine | 1 | 2021 | 11 | 0.040 |
Why?
|
| Feces | 1 | 2024 | 783 | 0.040 |
Why?
|
| Vaccines, DNA | 1 | 2021 | 49 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 790 | 0.040 |
Why?
|
| Bacteria | 1 | 2024 | 537 | 0.040 |
Why?
|
| Intestines | 1 | 2024 | 599 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2021 | 193 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2021 | 119 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2021 | 911 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 232 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2021 | 787 | 0.040 |
Why?
|
| Genes, Protozoan | 1 | 2018 | 26 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 1135 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1915 | 0.040 |
Why?
|
| Prevalence | 2 | 2016 | 2628 | 0.030 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2017 | 2 | 0.030 |
Why?
|
| Plasma | 1 | 2018 | 105 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2017 | 125 | 0.030 |
Why?
|
| Liver | 1 | 2024 | 1860 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2018 | 456 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2785 | 0.030 |
Why?
|
| Atrophy | 1 | 2017 | 232 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2021 | 932 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2018 | 1118 | 0.030 |
Why?
|
| Cytochromes b | 1 | 2015 | 6 | 0.030 |
Why?
|
| Population Density | 1 | 2015 | 34 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2017 | 333 | 0.030 |
Why?
|
| Cresols | 1 | 2014 | 6 | 0.030 |
Why?
|
| Sulfuric Acid Esters | 1 | 2014 | 8 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 3131 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2017 | 815 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2014 | 26 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 1325 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1584 | 0.030 |
Why?
|
| DNA, Helminth | 1 | 2014 | 23 | 0.030 |
Why?
|
| United States | 2 | 2024 | 11721 | 0.030 |
Why?
|
| Coinfection | 1 | 2016 | 182 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 196 | 0.030 |
Why?
|
| Ecology | 1 | 2013 | 16 | 0.030 |
Why?
|
| Trypanosoma | 1 | 2013 | 10 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 159 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 4917 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2018 | 997 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1770 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2013 | 254 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3415 | 0.020 |
Why?
|
| Metabolomics | 1 | 2014 | 471 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3960 | 0.020 |
Why?
|
| Adult | 3 | 2016 | 31674 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 1830 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2016 | 1597 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 5199 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 3731 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 13103 | 0.010 |
Why?
|
| Male | 2 | 2016 | 65576 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 28977 | 0.010 |
Why?
|